259 related articles for article (PubMed ID: 12538634)
21. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
[TBL] [Abstract][Full Text] [Related]
22. Analysis of protein complexes assembled on apolipoprotein B mRNA for mooring sequence-dependent RNA editing.
Smith HC
Methods; 1998 May; 15(1):27-39. PubMed ID: 9614650
[TBL] [Abstract][Full Text] [Related]
23. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
Sowden MP; Ballatori N; Jensen KL; Reed LH; Smith HC
J Cell Sci; 2002 Mar; 115(Pt 5):1027-39. PubMed ID: 11870221
[TBL] [Abstract][Full Text] [Related]
24. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.
Yamanaka S; Poksay KS; Driscoll DM; Innerarity TL
J Biol Chem; 1996 May; 271(19):11506-10. PubMed ID: 8626710
[TBL] [Abstract][Full Text] [Related]
25. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48.
Hirano K; Young SG; Farese RV; Ng J; Sande E; Warburton C; Powell-Braxton LM; Davidson NO
J Biol Chem; 1996 Apr; 271(17):9887-90. PubMed ID: 8626621
[TBL] [Abstract][Full Text] [Related]
26. Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity.
Blanc V; Henderson JO; Kennedy S; Davidson NO
J Biol Chem; 2001 Dec; 276(49):46386-93. PubMed ID: 11571303
[TBL] [Abstract][Full Text] [Related]
27. The hypothyroid (hyt/hyt) mouse: a model system for studying the effects of thyroid hormone on developmental changes in gene expression.
Green RP; Birkenmeier EH; Beamer WG; Maltais LJ; Gordon JI
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5592-6. PubMed ID: 3399505
[TBL] [Abstract][Full Text] [Related]
28. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
MacGinnitie AJ; Anant S; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.
Elam MB; von Wronski MA; Cagen L; Thorngate F; Kumar P; Heimberg M; Wilcox HG
Lipids; 1999 Aug; 34(8):809-16. PubMed ID: 10529091
[TBL] [Abstract][Full Text] [Related]
30. Hypermutation induced by APOBEC-1 overexpression can be eliminated.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Csako G; Patterson AP
RNA; 2010 May; 16(5):1040-52. PubMed ID: 20348446
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.
Chen Z; Eggerman TL; Patterson AP
Biochem J; 2001 Aug; 357(Pt 3):661-72. PubMed ID: 11463337
[TBL] [Abstract][Full Text] [Related]
32. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
Yang Y; Sowden MP; Smith HC
J Biol Chem; 2000 Jul; 275(30):22663-9. PubMed ID: 10833526
[TBL] [Abstract][Full Text] [Related]
33. Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene.
Henderson JO; Blanc V; Davidson NO
Biochim Biophys Acta; 2001 Nov; 1522(1):22-30. PubMed ID: 11718896
[TBL] [Abstract][Full Text] [Related]
34. Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker.
Lellek H; Welker S; Diehl I; Kirsten R; Greeve J
J Biol Chem; 2002 Jun; 277(26):23638-44. PubMed ID: 11976346
[TBL] [Abstract][Full Text] [Related]
35. Apobec-1 and apolipoprotein B mRNA editing.
Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
[TBL] [Abstract][Full Text] [Related]
36. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR
J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066
[TBL] [Abstract][Full Text] [Related]
37. Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA.
Srivastava RA
Biochem Biophys Res Commun; 1995 Jul; 212(2):381-7. PubMed ID: 7626051
[TBL] [Abstract][Full Text] [Related]
38. Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing.
Lau PP; Chan L
J Biol Chem; 2003 Dec; 278(52):52988-96. PubMed ID: 14559896
[TBL] [Abstract][Full Text] [Related]
39. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein B mRNA editing and the reduction in synthesis and secretion of the atherogenic risk factor, apolipoprotein B100 can be effectively targeted through TAT-mediated protein transduction.
Yang Y; Ballatori N; Smith HC
Mol Pharmacol; 2002 Feb; 61(2):269-76. PubMed ID: 11809850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
